Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,500 | N/A | -185,800 | -170,600 | -115,200 |
| Depreciation Amortization | 18,400 | N/A | 151,700 | 134,000 | 116,300 |
| Income taxes - deferred | -11,800 | N/A | -600 | -49,000 | -16,000 |
| Accounts receivable | -4,700 | N/A | 33,300 | 50,300 | 15,900 |
| Accounts payable and accrued liabilities | 300 | N/A | -2,600 | 600 | 9,200 |
| Other Working Capital | 91,400 | N/A | -15,000 | 119,800 | 25,700 |
| Other Operating Activity | 17,700 | 0 | 6,500 | -38,300 | -19,100 |
| Operating Cash Flow | $71,800 | $N/A | $-12,500 | $46,800 | $16,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,100 | N/A | -6,800 | -5,300 | -3,000 |
| Net Acquisitions | N/A | N/A | 21,300 | 21,300 | 21,300 |
| Purchase Of Investment | 0 | N/A | -15,800 | -15,800 | -15,800 |
| Sale Of Investment | 15,300 | N/A | 51,900 | 33,400 | 20,700 |
| Investing Cash Flow | $8,200 | $N/A | $50,600 | $33,600 | $23,200 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -70,000 | N/A | 0 | N/A | N/A |
| Common Stock Issued | 26,500 | N/A | 2,200 | 2,200 | 300 |
| Other Financing Activity | -5,000 | 0 | -5,000 | -1,100 | -100 |
| Financing Cash Flow | $-48,500 | $N/A | $-2,800 | $1,100 | $200 |
| Exchange Rate Effect | 400 | N/A | 300 | -500 | -1,900 |
| Beginning Cash Position | 117,000 | N/A | 81,200 | 81,200 | 81,200 |
| End Cash Position | 148,900 | N/A | 118,300 | 163,700 | 121,000 |
| Net Cash Flow | $31,900 | $N/A | $37,100 | $82,500 | $39,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 71,800 | N/A | -12,500 | 46,800 | 16,800 |
| Capital Expenditure | -7,100 | N/A | -6,800 | -5,300 | -3,000 |
| Free Cash Flow | 64,700 | 0 | -19,300 | 41,500 | 13,800 |